Oxford BioDynamics Plc (AIM:OBD)
London · Delayed Price · Currency is GBP · Price in GBX 0.1100
0.00 (0.00%)
Jul 6, 2026, 4:35 PM GMT
Oxford BioDynamics Market Cap
Oxford BioDynamics has a market cap or net worth of 4.72 million as of July 6, 2026. Its market cap has decreased by -36.21% in one year.
Market Cap
4.72M
Enterprise Value
6.49M
Revenue
1.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since December 6, 2016, Oxford BioDynamics's market cap has decreased from 136.90M to 4.72M, a decrease of -96.55%. That is a compound annual growth rate of -29.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 4.72M | -48.84% |
| Dec 31, 2025 | 9.23M | 92.61% |
| Dec 31, 2024 | 4.79M | -91.54% |
| Dec 29, 2023 | 56.64M | 125.13% |
| Dec 30, 2022 | 25.16M | -34.45% |
| Dec 31, 2021 | 38.38M | -50.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fusion Antibodies | 15.00M |
| Palatin Technologies | 14.43M |
| Genflow Biosciences | 11.61M |
| Cizzle Biotechnology Holdings | 10.62M |
| OptiBiotix Health | 6.66M |
| CRISM Therapeutics | 5.69M |
| Thalia Therapeutics | 5.41M |
| Nuformix | 4.70M |